Abnormalities of triiodothyronine binding to lymphocyte and fibroblast nuclei from a patient with peripheral tissue resistance to thyroid hormone action
- PMID: 233694
- DOI: 10.1210/jcem-47-6-1266
Abnormalities of triiodothyronine binding to lymphocyte and fibroblast nuclei from a patient with peripheral tissue resistance to thyroid hormone action
Abstract
T3 binding to lymphocyte nuclei has been studied in normal individuals and in a patient (MaG) with peripheral resistance to thyroid hormone action. This syndrome is defined by the presence of hypothyroidism or euthyroidism with high plasma levels of thyroid hormone. T3 bound to a single set of binding sites in normal adult lymphocyte nuclei with a mean Ka of 8.9 +/- 7.1 x 109 M-1, and a capacity of 4.4 +/- 2.9 fmol/100 micrograms DNA. A single binding site was also disclosed in MaG's lymphocytes with a Ka of 0.43 x 109 M-1 and a capacity of 10.5 fmol/100 micrograms DNA. This low affinity was not due to the presence of high plasma T3 level in the patient, since administration of 100 micrograms T3 to normal adult volunteers induced the presence of two different binding sites. The mechanism responsible for this phenomenon is unknown. To binding was also studied using cultured fibroblasts which were incubated in serum-less medium before the binding experiments. One single binding site (Ka, 1.9 x 10(10) M-1, capacity, 12.9 fmol/100 micrograms DNA) was detected in normal fibroblast nuclei. In contrast, a curvilinear Scatchard plot was obtained when MaG's fibroblasts were used. This result could be compatible with the presence of either two different binding sites or negative cooperativity. In support of the latter possibility, Hill plots gave a number lower than unity. The results suggest that the syndrome of peripheral tissue resistance to thyroid hormone action due to a defect at the level of the nuclear receptor. The possible existence of similar syndromes due to an alteration at the level of a post-T3-binding mechanism is not eliminated.
Similar articles
-
Peripheral resistance to thyroid hormone in an infant.J Clin Endocrinol Metab. 1981 Nov;53(5):958-63. doi: 10.1210/jcem-53-5-958. J Clin Endocrinol Metab. 1981. PMID: 6793616
-
Decreased nuclear uptake of [125I]triiodo-L-thyronine in fibroblasts from patients with peripheral thyroid hormone resistance.J Clin Endocrinol Metab. 1984 Dec;59(6):1081-7. doi: 10.1210/jcem-59-6-1081. J Clin Endocrinol Metab. 1984. PMID: 6092406
-
Partial peripheral resistance to thyroid hormones, a post-receptor defect?Horm Metab Res Suppl. 1984;14:20-3. Horm Metab Res Suppl. 1984. PMID: 6096250
-
[Syndrome of resistance to thyroid hormones].Presse Med. 1993 Nov 27;22(37):1870-5. Presse Med. 1993. PMID: 8115332 Review. French.
-
[Mechanism of action of thyroid hormones at the cellular level].Ann Endocrinol (Paris). 1983;44(4):205-16. Ann Endocrinol (Paris). 1983. PMID: 6322666 Review. French.
Cited by
-
A case of hypersensitivity to thyroid hormones with normally functioning thyroid gland and increased nuclear triiodothyronine receptors.J Endocrinol Invest. 1990 Nov;13(10):839-45. doi: 10.1007/BF03349636. J Endocrinol Invest. 1990. PMID: 2128940
-
New insights on the mechanism(s) of the dominant negative effect of mutant thyroid hormone receptor in generalized resistance to thyroid hormone.J Clin Invest. 1992 Nov;90(5):1825-31. doi: 10.1172/JCI116058. J Clin Invest. 1992. PMID: 1430208 Free PMC article.
-
Receptor-mediated uptake of 3,3',5-triiodo-L-thyronine by cultured fibroblasts.Proc Natl Acad Sci U S A. 1980 Jun;77(6):3425-9. doi: 10.1073/pnas.77.6.3425. Proc Natl Acad Sci U S A. 1980. PMID: 6158047 Free PMC article.
-
Thyroid hormone receptors and stimulation of angiotensinogen production in HepG2 cells.In Vitro Cell Dev Biol. 1991 Jan;27(1):21-4. doi: 10.1007/BF02630890. In Vitro Cell Dev Biol. 1991. PMID: 1849506
-
Familial generalized resistance to thyroid hormones: report of three kindreds and correlation of patterns of affected tissues with the binding of [125I] triiodothyronine to fibroblast nuclei.J Endocrinol Invest. 1986 Dec;9(6):459-70. doi: 10.1007/BF03346968. J Endocrinol Invest. 1986. PMID: 3571851
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials